Download "user manual"

7.7 Applications in clinical research using other ILFT equipment
 Peterson-Carmichael S, Rosenfeld M, Ascher SB, et al. Survey of Clinical Infant Lung Function
Testing Practices. Pediatr Pulmonol 2014;49: 126-131
 Debley J, Stanojevic S, Filbrun AG, et al. Bronchodilator responsiveness in wheezy infants and
toddlers is not associated with asthma risk factors. Pediatr Pulmonol 2012; 47: 421-428
 Spoel M, van den Hout L, Gischler SJ, et al. Prospective longitudinal evaluation of lung
function during the first year of life after repair of congenital diaphragmatic hernia. Pediatr
Crit Care Med 2012; 13: e133-e139.
 Rosenfeld M, Ratjen F, Brumback L, et al. Inhaled hypertonic saline in infants and children
younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. JAMA 2012;
307: 2269-2277.
 Prendergast M, Rafferty GF, Milner AD, et al. Lung function at follow-up of infants with
surgically correctable anomalies. Pediatr Pulmonol 2012; 47: 973-978.
 van der Zalm MM, Uiterwaal CS, Wilbrink B, et al. The influence of neonatal lung function on
rhinovirus-associated wheeze. Am J Respir Crit Care Med 2011; 183: 262-267.
 Pillarisetti N, Williamson E, Linnane B, et al. Infection, inflammation, and lung function
decline in infants with cystic fibrosis. Am J Respir Crit Care Med 2011; 184: 75-81.
 Filbrun AG, Popova AP, Linn MJ, et al. Longitudinal measures of lung function in infants with
bronchopulmonary dysplasia. Pediatr Pulmonol 2011; 46: 369-375.
 Drysdale SB, Wilson T, Alcazar M, et al. Lung function prior to viral lower respiratory tract
infections in prematurely born infants. Thorax 2011; 66: 468-473.
 McEvoy C, Schilling D, Peters D, et al. Respiratory compliance in preterm infants after a single
rescue course of antenatal steroids: a randomized controlled trial. Am J Obstet Gynecol
2010; 202: 544-549.
 Davis SD, Rosenfeld M, Kerby GS, et al. Multicenter evaluation of infant lung function tests as
cystic fibrosis clinical trial endpoints. Am J Respir Crit Care Med 2010; 182: 1387-1397.
 Colin AA, McEvoy C, Castile RG. Respiratory morbidity and lung function in preterm infants of
32 to 36 weeks' gestational age. Pediatrics 2010; 126: 115-128.
 Ranganathan S, Linnane B, Nolan G et al. Early detection of lung disease in children with
cystic fibrosis using lung function. Paediatr Respir Rev 2008; 9: 160-167.
 McEvoy C, Schilling D, Spitale P, et al. Decreased respiratory compliance in infants less than
or equal to 32 weeks' gestation, delivered more than 7 days after antenatal steroid therapy.
Pediatrics 2008; 121: e1032-e1038.
 Linnane BM, Hall GL, Nolan G, et al. Lung function in infants with cystic fibrosis diagnosed by
newborn screening. Am J Respir Crit Care Med 2008; 178: 1238-1244.
 Broughton S, Sylvester KP, Fox G, et al. Lung function in prematurely born infants after viral
lower respiratory tract infections. Pediatr Infect Dis J 2007; 26: 1019-1024.
 Yemen S, Gaston B. Lung function test results in normal infants: a COPSAC sequel. J Allergy Clin
Immunol 2009; 123: 658-659.
 Bisgaard H, Loland L, Holst KK, et al. Prenatal determinants of neonatal lung function in high-risk
newborns. J Allergy Clin Immunol 2009; 123: 651-657, 657.
189